Trauma i hitna medicina
Kontroliranje i optimizacija hemostaze
Antifibrinolitička sredstva
Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. (otvara se novi prozor)
Izvor: Lancet 2019;394(10210):1713-23.
Indeks: PubMed 31623894
DOI: 10.1016/S0140-6736(19)32233-0
https://www.ncbi.nlm.nih.gov/pubmed/31623894 (otvara se novi prozor)
Alternatives to allogeneic platelet transfusion. (otvara se novi prozor)
Izvor: Br J Haematol 2016;175(3):381-92.
Indeks: PubMed 27650431
DOI: 10.1111/bjh.14338
https://www.ncbi.nlm.nih.gov/pubmed/27650431 (otvara se novi prozor)
Antifibrinolytic drugs for acute traumatic injury. (otvara se novi prozor)
Izvor: Cochrane Database Syst Rev 2015;(5):CD004896.
Indeks: PubMed 25956410
DOI: 10.1002/14651858.CD004896.pub4
https://www.ncbi.nlm.nih.gov/pubmed/25956410 (otvara se novi prozor)
Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury: findings from the MATTERs II Study. (otvara se novi prozor)
Izvor: JAMA Surg 2013;148(3):218-25.
Indeks: PubMed 23670117
DOI: 10.1001/jamasurg.2013.764
https://www.ncbi.nlm.nih.gov/pubmed/23670117 (otvara se novi prozor)
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. (otvara se novi prozor)
Izvor: Lancet 2011;377(9771):1096-101, 1101.e1-2.
Indeks: PubMed 21439633
DOI: 10.1016/S0140-6736(11)60278-X
https://www.ncbi.nlm.nih.gov/pubmed/21439633 (otvara se novi prozor)
Topical tranexamic acid compared with anterior nasal packing for treatment of epistaxis in patients taking antiplatelet drugs: randomized controlled trial. (otvara se novi prozor)
Izvor: Acad Emerg Med 2018;25(3):261-6.
Indeks: PubMed 29125679
DOI: 10.1111/acem.13345
https://www.ncbi.nlm.nih.gov/pubmed/29125679 (otvara se novi prozor)
Rekombinirani aktivirani faktor VII (rFVIIa)
Efficacy of recombinant activated Factor VII in patients with massive uncontrolled bleeding: a retrospective observational analysis. (otvara se novi prozor)
Izvor: Transfusion 2009;49(3):570-7.
Indeks: PubMed 19040498
DOI: 10.1111/j.1537-2995.2008.02001.x
https://www.ncbi.nlm.nih.gov/pubmed/19040498 (otvara se novi prozor)
The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage. (otvara se novi prozor)
Izvor: Transfusion 2009;49 Suppl 5:240S-7S.
Indeks: PubMed 19954486
DOI: 10.1111/j.1537-2995.2008.01987.x
https://www.ncbi.nlm.nih.gov/pubmed/19954486 (otvara se novi prozor)
Koncentrati faktora zgrušavanja
The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma. (otvara se novi prozor)
Izvor: Injury 2013;44(2):209-16.
Indeks: PubMed 23000050
DOI: 10.1016/j.injury.2012.08.047
https://www.ncbi.nlm.nih.gov/pubmed/23000050 (otvara se novi prozor)
Dezmoprezin
Desmopressin is a transfusion sparing option to reverse platelet dysfunction in patients with severe traumatic brain injury. (otvara se novi prozor)
Izvor: J Trauma Acute Care Surg 2020;88(1):80-6.
Indeks: PubMed 31688782
DOI: 10.1097/TA.0000000000002521
https://www.ncbi.nlm.nih.gov/pubmed/31688782 (otvara se novi prozor)
Viskoelastični testovi za otkrivanje kirurškog ili koagulopatijskog krvarenja
Successful rotational thromboelastometry-guided treatment of traumatic haemorrhage, hyperfibrinolysis and coagulopathy. (otvara se novi prozor)
Izvor: Acta Anaesthesiol Scand 2010;54(1):111-7.
Indeks: PubMed 19860752
DOI: 10.1111/j.1399-6576.2009.02132.x
https://www.ncbi.nlm.nih.gov/pubmed/19860752 (otvara se novi prozor)
Use of rotation thromboelastometry (ROTEM) to achieve successful treatment of polytrauma with fibrinogen concentrate and prothrombin complex concentrate. (otvara se novi prozor)
Izvor: Anaesthesia 2010;65(2):199-203.
Indeks: PubMed 19995349
https://www.ncbi.nlm.nih.gov/pubmed/19995349 (otvara se novi prozor)